RenovoRx Inc (RNXT)
1.26
-0.12
(-8.70%)
USD |
NASDAQ |
Mar 28, 14:38
RenovoRx Total Liabilities (Quarterly): 3.513M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 3.513M |
June 30, 2023 | 5.126M |
March 31, 2023 | 1.305M |
December 31, 2022 | 1.102M |
September 30, 2022 | 1.102M |
June 30, 2022 | 1.123M |
Date | Value |
---|---|
March 31, 2022 | 1.406M |
December 31, 2021 | 0.938M |
September 30, 2021 | 0.625M |
June 30, 2021 | 19.22M |
March 31, 2021 | 17.04M |
December 31, 2020 | 16.57M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.625M
Minimum
Sep 2021
19.22M
Maximum
Jun 2021
5.756M
Average
1.356M
Median
Total Liabilities (Quarterly) Benchmarks
Corcept Therapeutics Inc | 114.81M |
Voyager Therapeutics Inc | 114.96M |
Aditxt Inc | 12.45M |
Cardio Diagnostics Holdings Inc | 3.676M |
Fortress Biotech Inc | 163.79M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.519M |
Shareholders Equity (Quarterly) | 0.006M |